文献速递肝胆胰外科围术期管理与 ERAS

远端胰腺切除术后临床相关胰瘘的早期生化预测指标:血清淀粉酶与C反应蛋白的作用

Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein.
PubMed 文献 · Surg Endosc · 2022-01-06

该研究回顾了432例连续远端胰腺切除术患者的临床与实验室数据,评估术后早期生化标志物对临床相关术后胰瘘(CR-POPF)的预测价值。结果显示术后90天内CR-POPF发生率为36%,严重并发症发生率为15%;多变量分析确定男性、POD2引流液淀粉酶≥1500 U/L、POD1血清淀粉酶≥100 U/L及POD3 CRP较前一日升高至少25 mg/L为CR-POPF的独立预测因素。结论提示除引流液淀粉酶外,术后血清淀粉酶和CRP变化轨迹是有用的早期生化标志物,可纳入临床实践以辅助术后患者和引流管管理。

要点

  • POD2引流液淀粉酶≥1500 U/L是CR-POPF的独立预测因素(OR 4.63)。
  • POD1血清淀粉酶≥100 U/L是CR-POPF的独立预测因素(OR 1.72)。
  • POD3 CRP较前一日升高至少25 mg/L是CR-POPF的独立预测因素(OR 1.89)。

核心结论

  • 术后血清淀粉酶和CRP变化轨迹是除引流液淀粉酶外预测远端胰腺切除术后CR-POPF的有用早期生化标志物。
  • 研究提示这些实验室检查应纳入临床实践以辅助术后患者和引流管管理。

研究设计与样本

  • 回顾性分析432例连续远端胰腺切除术患者的临床和实验室数据。
  • 术后第1天评估血清淀粉酶,术后第2天和第3天评估引流液淀粉酶和C反应蛋白。
  • 采用ROC曲线计算曲线下面积,多变量回归分析确定CR-POPF和严重术后并发症(Clavien-Dindo分级≥3)的相关因素。

主要发现

  • 术后90天时,155例(36%)患者发生CR-POPF,66例(15%)患者发生严重并发症。
  • ROC曲线分析显示POD2引流液淀粉酶的AUC最大(0.753,p < 0.001),其次为POD1血清淀粉酶(0.651,p < 0.001)、POD3血清CRP(0.644,p < 0.001)以及POD2至POD3的CRP变化(0.644,p < 0.001)。
  • 多变量分析确定男性(OR 2.29,95% CI 1.36-3.86;p = 0.002)、POD2引流液淀粉酶≥1500 U/L(OR 4.63,95% CI 2.72-7.89;p < 0.001)、POD1血清淀粉酶≥100 U/L(OR 1.72,95% CI 1.01-2.93;p = 0.046)以及POD3 CRP较前一日升高至少25 mg/L(OR 1.89,95% CI 1.11-3.21;p = 0.019)为CR-POPF的独立预测因素,回归模型有效(AUC 0.765,95% CI 0.714-0.816,p < 0.001)。

临床怎么用

  • 术后早期检测血清淀粉酶、引流液淀粉酶和CRP变化轨迹可能有助于识别CR-POPF高风险患者。
  • 研究建议将这些实验室检查纳入临床实践以辅助术后患者和引流管管理。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent evidence suggests that pancreatic inflammation plays a pivotal role in the occurrence of clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreaticoduodenectomy but few data are available for distal pancreatectomy (DP). The aim of this study was to evaluate the impact of early biochemical markers on the occurrence of CR-POPF after DP. METHODS: Clinical and laboratory data for 432 consecutive DP patients were reviewed. Serum amylase was evaluated on postoperative day (POD) 1, and drain fluid amylase (DFA) and C-reactive protein (CRP) were evaluated on POD 2 and 3. Receiver operator characteristic (ROC) curves were performed for all biochemical markers and an area under the curve (AUC) was computed. Multivariable regression analyses to identify the factors associated with CR-POPF and severe postoperative morbidity (Clavien-Dindo grade ≥ 3) were performed. RESULTS: At 90 days after surgery, CR-POPF occurred in 155 (36%) patients, severe complications in 66 (15%) patients. ROC curve analyses showed that DFA on POD2 had the largest AUC (0.753, p < 0.001), followed by serum amylase on POD 1 (0.651, p < 0.001), serum CRP on POD3 (0.644, p < 0.001), and CRP change between POD 2 and POD 3 (0.644, p < 0.001). Multivariable analysis identified male gender (OR 2.29, 95% CI 1.36-3.86; p = 0.002), DFA ≥ 1500 U/L on POD2 (OR 4.63, 95% CI 2.72-7.89; p < 0.001), serum amylase ≥ 100 U/L on POD 1 (OR 1.72, 95% CI 1.01-2.93; p = 0.046), and CRP increase by at least 25 mg/L on POD 3 compared to the previous day (OR 1.89, 95% CI 1.11-3.21; p = 0.019) as independent predictors of CR-POPF, yielding a valid regression model (AUC 0.765, 95% CI 0.714-0.816, p < 0.001). CONCLUSIONS: Postoperative serum amylase and CRP trajectory represent useful early biochemical markers for CR-POPF in addition to DFA. Our findings suggest that these laboratory tests should be incorporated into clinical practice to aid postoperative patient and drain management.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Pecorelli N, Guarneri G, Palucci M, et al. Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein. Surg Endosc. 2022. PMID: 34988737. doi:10.1007/s00464-021-08883-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。